Skip to main content
. Author manuscript; available in PMC: 2022 Jan 20.
Published in final edited form as: Am J Obstet Gynecol. 2018 Feb 17;218(6):604.e1–604.e8. doi: 10.1016/j.ajog.2018.02.009

Table 5.

Disease detected in follow-up by risk strata

Stratum (Colposcopy impression/
cytology/ HPV16)		 Women
in
stratum		 Women without
CIN2+ at
baseline		 Women
with follow
up		 N HSIL+
cytology or
CIN2+ histology
during follow-up		 Risk in women
without CIN2+ at
baseline		 NPV
High grade/ HSIL/ HPV16+ 58 11 7 (64%) 1 14% 86%
High grade/ <HSIL/ HPV16+ 26 6 4 (67%) 2 50% 50%
Low grade/ HSIL/ HPV16+ 26 7 3 (43%) 0 0% 100%
High grade/ HSIL/ HPV16− 51 16 12 (75%) 0 0% 100%
Low grade/ <HSIL/ HPV16+ 57 25 17 (68%) 1 6% 94%
Low grade/ HSIL/ HPV16− 53 29 20 (69%) 0 0% 100%
High grade/ <HSIL/ HPV16− 76 45 20 (44%) 1 5% 95%
Low grade/ <HSIL/ HPV16− 191 146 76 (52%) 3 4% 96%
Normal or acetowhitening/ <HSIL/ HPV16− 81 76 36 (47%) 0 0% 100%
Total 619 361 195 (54%) 8 4% 96%

HSIL: High grade squamous intraepithelial lesion; high-risk categories are shown in bold; CIN2+: cervical intraepithelial neoplasia grade 2 or higher; NPV:negative predictive value